| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Reviva Pharmaceuticals Holdings, Inc. (RVPH) has 5 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. RVPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 40.9K | $35.0K | - | |
| Dir | 8.2K | $7.0K | - | |
| Dir | 8.2K | $7.0K | - | |
| Dir | 8.2K | $7.0K | - | |
| Dir | 8.2K | $7.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2018 | Nayar Rahul | Chief Executive Officer | Buy | 33,000 | $10.00 | $330,000.00 | +1.7% | |
| Aug 30, 2018 | Saxena Parag | Chairman Of The Board | Buy | 33,000 | $10.00 | $330,000.00 | +1.7% | |
| Aug 23, 2018 | Nayar Rahul | Chief Executive Officer | Buy | 310,000 | $10.00 | $3,100,000.00 | +19.6% | |
| Aug 23, 2018 | Saxena Parag | Chairman Of The Board | Buy | 310,000 | $10.00 | $3,100,000.00 | +19.6% | |
| Aug 23, 2018 | Tenzing LLC | 10% Owner | Buy | 310,000 | $10.00 | $3,100,000.00 | +19.6% |